Azathioprine in inflammatory bowel disease, a safe alternative?

被引：20
|
作者：
Tanis, AA [1 ]
机构：
[1] Erasmus Univ, Hosp Dijkzigt, Dept Gastroenterol & Hepatol, NL-3015 GD Rotterdam, Netherlands
来源：
MEDIATORS OF INFLAMMATION | 1998年 / 7卷 / 03期
关键词：
azathioprine; 6-mercaptopurine; inflammatory bowel disease; bone marrow suppression; side effects; pregnancy;
D O I：
10.1080/09629359891045
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
AZATHIOPRINE and its metabolite 6-mercaptopurine are effective in the treatment of inflammatory bowel disease. They are mostly used for reduction of the use of steroids, maintenance therapy after remission induction by cyclosporin and treatment of fistulae in Crohn's disease. Adverse effects occur in about 15% of patients. The main side effects are pancreatitis, allergic reactions, fever and bone marrow suppression. Symptoms, management and prevention are discussed. A blood monitoring schedule is suggested. Azathioprine and 6-mercaptopurine seem to be safe in pregnancy. There may be a slight increased risk for developing a non-Hodgkin's lymphoma.
引用
收藏
页码：141 / 144
页数：4
相关论文
共 50 条
  • [41] Side Effects of Azathioprine in the Treatment of Chronic Inflammatory Bowel Disease
    Avallone, Eleonora V.
    Pica, Roberta
    Cassieri, Claudio
    De Carolis, Aurora
    Paoluzi, Paolo
    Vernia, Piero
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A681 - A681
  • [42] AZATHIOPRINE, 6-MERCAPTOPURINE, AND INFLAMMATORY BOWEL-DISEASE
    BEAUGERIE, L
    GENDRE, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (03): : 230 - 240
  • [43] Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine
    Su, CY
    Lichtenstein, GR
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 209 - +
  • [44] Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
    Ansari, A
    Hassan, C
    Duley, J
    Marinaki, A
    Shobowale-Bakre, EM
    Seed, P
    Meenan, J
    Yim, A
    Sanderson, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1743 - 1750
  • [45] Azathioprine side effects in the treatment of chronic inflammatory bowel disease
    Lara, VG
    Calle, JLN
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2001, 93 (12) : 767 - 768
  • [46] High-dose azathioprine in children with inflammatory bowel disease
    Fuentes, D
    Torrente, F
    Keady, S
    Thirrupathy, K
    Thomson, MA
    Walker-Smith, JA
    Murch, SH
    Heuschkel, RB
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) : 913 - 921
  • [47] LOWER LYMPHOCYTE COUNTS AND AZATHIOPRINE EFFICACY IN INFLAMMATORY BOWEL DISEASE
    Subramaniam, S.
    Hawkey, C. J.
    [J]. GUT, 2010, 59 : A100 - A100
  • [48] Audit of longterm azathioprine use in inflammatory bowel disease.
    Chew, C
    Evans, C
    Curry, G
    Penney, C
    Cochran, K
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1337 - A1337
  • [49] Efficacy and safety of azathioprine in inflammatory bowel disease: UK experience
    Jalal, PK
    Brown, J
    Nagvi, A
    Moss, S
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A499 - A499
  • [50] Laparoscopic Total Proctocolectomy: An Incisionless Alternative to Open Surgery and a Safe Approach in Inflammatory Bowel Disease
    Holder-Murray, Jennifer
    Hurst, Roger D.
    Umanskiy, Konstantin
    Rubin, Michele A.
    Fichera, Alessandro
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A891 - A891
12345